top of page

About the Institute of Life Sciences

"At our institute, we conduct research with a major focus on regenerative medicine. Our main businesses are the stem cell therapy business, which we conduct in collaboration with the attached clinic, the stem cell supernatant business, which is used in cosmetics and as a treatment in the clinic, and the iPS business, which conducts research to prepare for future health risks. In addition, our businesses are run primarily by researchers with doctoral degrees in a variety of specialties, including bioscience. Through regenerative medicine, we are conducting research every day to support healthier lives for everyone.


About the Institute of Life Sciences

iPS banking business

In compliance with GMP (Good Manufacturing Practice) standards, we create iPS cells from human somatic cells, conduct safety tests, measure performance (such as differentiation ability), and store the cells safely while maintaining quality.

Stem cell supernatant business

Our institute is conducting research using stem cells derived from human adipose tissue. The supernatant produced from these stem cells is used as a raw material for cosmetics and other products.

Water blister 1.jpg
Petri dish.jpg

Stem cell therapy business

In cooperation with the adjacent clinic, we provide treatments focusing on stem cells derived from human adipose tissue, a type of somatic stem cell that is attracting attention as a raw material for regenerative medicine.

CPC supports business safety

The Cell Culture Processing Facility (CPC), which supports the safety of our institute, complies with Ministry of Health, Labor and Welfare Ordinance No. 110 (September 26, 2014).

CPC Overview (What is the Life Science Institute?)_edited_edited.png

Director of the Institute of Life Sciences, Dr. Sosuke Iizuka


  • 2008: Tokyo Medical and Dental University, School of Medicine, Graduate

  • 2021: University of Tokyo Graduate School of Medicine and Dentistry, Graduate


■Professional Experience

  • 2008: Tokyo Metropolitan Matsuzawa Hospital

  • 2010: Ibaraki Prefectural Central Hospital, Department of Oncology

  • 2013: Japanese Red Cross Society Medical Center

  • 2018: Tokyo Metropolitan Matsuzawa Hospital (Part-time)


■Current Position

  • President, Keishin Medical Corporation


■Licenses and Certifications

  • Graduate, Tokyo Medical and Dental University, School of Medicine

  • Certified Internist, Japanese Society of Internal Medicine

  • Hematologist, Japanese Society of Hematology

  • General Internist, Japanese Society of Internal Medicine

  • Member, Japanese Society of Psychiatry and Neurology

  • Member, Regenerative Medicine Society

  • Doctor of Medicine

Photo taken around 2008

Photo taken around 2008

We will create your iPS cells to prepare for future risks.
Please feel free to contact us.

bottom of page